WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
This Quarter Return
+19.42%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$2.33B
AUM Growth
+$2.33B
(+35%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
15.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
6
Reduced
–
Closed
–
Top Buys
| 1 |
AbbVie
ABBV
|
$208M |
| 2 |
Theravance Biopharma
TBPH
|
$77M |
| 3 |
Alkermes
ALKS
|
$26.1M |
| 4 |
NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
|
$17.5M |
| 5 |
RAI
Reynolds American Inc
RAI
|
$12.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 66.96% |
| 2 | Consumer Staples | 33.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAI
1
DELISTED
Reynolds American Inc
RAI
| $770M | 33.04% | 16,684,590 +277,300 | +2% | +$12.8M |
|
|
2
AbbVie
ABBV
$372B
| $521M | 22.35% | 8,794,000 +3,516,200 | +67% | +$208M |
|
|
3
Alkermes
ALKS
$4.78B
| $439M | 18.85% | 5,535,569 +328,936 | +6% | +$26.1M |
|
4
Prothena Corp
PRTA
$441M
| $435M | 18.64% | 6,379,661 +177,136 | +3% | +$12.1M |
|
|
5
Theravance Biopharma
TBPH
$699M
| $83M | 3.56% | 5,061,637 +4,700,952 | +1,303% | +$77M |
|
|
NWBO
6
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $82.9M | 3.56% | 25,915,937 +5,454,545 | +27% | +$17.5M |
|